Investigation of Inspiratory Muscle Training Applied at Different Intensities on Intercostal Muscle Oxygenation

ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorKirsehir Ahi Evran Universitesi

About this trial

In this study, it was aimed to investigate the acute effect of inspiratory muscle training of different intensities on intercostal muscle oxygenation in healthy individuals.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Physically active (doing moderate intensity physical activity for at least 3 days a week for 150 minutes / week)

Volunteer to participate in the study

Disqualifiers

Healthy individuals with any diagnosed chronic or systemic disease,

Smoke 10 packs x years or more,

Pneumonia or any acute infection,

Psychiatric disorder will excluded in the study.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Sham inspiratory muscle training (MIP 0%)

    Device

    POWERbreathe Wellness (POWERbreathe International Ltd.., England, UK) device will be used for inspiratory muscle training.

  • MIP 30% inspiratory muscle training

    Device

    POWERbreathe Wellness (POWERbreathe International Ltd.., England, UK) device will be used for inspiratory muscle training.

  • MIP 70% inspiratory muscle training

    Other intervention

    POWERbreathe Wellness (POWERbreathe International Ltd.., England, UK) device will be used for inspiratory muscle training.

Treatment groups

27 Participants
are divided into 3 treatment groups
Group A: Sham inspiratory muscle training (Maximal inspiratory pressure (MIP) 0%)Experimental treatment 1 intervention
Group B: MIP 30% inspiratory muscle trainingExperimental treatment 1 intervention
Group C: MIP 70% inspiratory muscle trainingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Evaluation of intercostal muscle oxygenation

Before the inspiratory muscle training sessions, the muscle oxygen saturation (SmO2) of the intercostal muscles in recovery during and after the training session will be measured using a Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA).

Time frame
Second, Third and Fourth day
2

Evaluation of intercostal muscle total hemoglobin level

Before the inspiratory muscle training sessions, total hemoglobin level (THb) of the intercostal muscles in recovery during and after the training session will be measured using a Moxy® monitor (Moxy, Fortiori Design LLC, Minnesota, USA).

Time frame
Second, Third and Fourth day

Secondary outcomes

1

Evaluation of respiratory muscle strength

An electronic mouth pressure device will be used to evaluate respiratory muscle strength. Patients will have maximal inspiratory pressure and maximal expiratory pressure measured with a mouth pressure measuring device.

Time frame
First day
2

Evaluation of respiratory muscle endurance

The incremental threshold loading test will be used to evaluate respiratory muscle endurance. The PowerBreathe Wellness® (HaB International Ltd. Southam, UK) will be used in the incremental threshold loading test.

Time frame
First day
3

Evaluation of pulmonary function (Forced expiratory volume in the first second (FEV1))

Measurement of FEV1 will be performed with spirometer according to the criteria of the American Thoracic Society and the European Respiratory Society.

Time frame
First day
4

Evaluation pulmonary function (Forced vital capacity (FVC))

Measurement of FVC will be performed with spirometer according to the criteria of the American Thoracic Society and the European Respiratory Society.

Time frame
First day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.